J7173
HCPCSInj. concizumab-mtci, 0.5 mg
Official HCPCS Level II long descriptor
Injection, concizumab-mtci, 0.5 mg
HCPCS Level II code J7173 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj. concizumab-mtci, 0.5 mg
Added to HCPCS: 2025-10-01
Nearby codes in J7
- J71215% dextrose in lac ringers
- J7131Hypertonic saline sol
- J7165Inj, human-lans, per i.u
- J7168Prothrombin complex kcentra
- J7169Inj andexxa, 10 mg
- J7170Inj., emicizumab-kxwh 0.5 mg
- J7171Inj, adzynma, 10 iu
- J7172Inj marstacim-hncq, 0.5 mg
- J7174Injection fitusiran 0.04 mg
- J7175Inj, factor x, (human), 1iu
- J7176Inj. fesilty, 1 mg
- J7177Inj., fibryga, 1 mg
- J7178Inj human fibrinogen con nos
- J7179Vonvendi inj 1 iu vwf:rco
- J7180Factor xiii anti-hem factor
- J7181Factor xiii recomb a-subunit
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.